These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4917968)

  • 1. A controlled trial of combined medications on behavioral and extrapyramidal effects.
    Simpson GM; Krakov L; Kunz-Bartholini E
    Acta Psychiatr Scand Suppl; 1970; 212():20-7. PubMed ID: 4917968
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.
    Prusoff BA; Williams DH; Weissman MM; Astrachan BM
    Arch Gen Psychiatry; 1979 May; 36(5):569-75. PubMed ID: 373665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Hanlon TE; Schoenrich C; Freinek W; Turek I; Kurland AA
    Psychopharmacologia; 1966; 9(4):328-39. PubMed ID: 4874349
    [No Abstract]   [Full Text] [Related]  

  • 4. A rating scale for extrapyramidal side effects.
    Simpson GM; Angus JW
    Acta Psychiatr Scand Suppl; 1970; 212():11-9. PubMed ID: 4917967
    [No Abstract]   [Full Text] [Related]  

  • 5. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
    Gottfries CG
    Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics.
    Collins AD; Dundas J
    Br J Psychiatry; 1967 Dec; 113(505):1425-9. PubMed ID: 4865295
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled comparison of the treatment of schizophrenic patients when treated according to the neurologic threshold or by clinical judgment.
    Simpson GM; Krakov L; Mattke D; St Phard G
    Acta Psychiatr Scand Suppl; 1970; 212():38-43. PubMed ID: 4917970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extrapyramidal syndrome and spondyloarthritis ankylopoietica in a schizophrenic patient].
    Lipiński B
    Psychiatr Pol; 1970; 4(2):211-4. PubMed ID: 5427765
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C; Oliveros R; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603
    [No Abstract]   [Full Text] [Related]  

  • 10. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.
    Anton RF; Burch EA
    Am J Psychiatry; 1990 Sep; 147(9):1203-8. PubMed ID: 2201223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled outpatient trial of perphenazine--amitriptyline and chlorpromazine.
    Haskell DS; McNair DM; Fisher S; Kahn RJ
    J Clin Pharmacol; 1974 Oct; 14(10):536-42. PubMed ID: 4610016
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.
    Clark ML; Ramsey HR; Ragland RE; Rahhal DK; Serafetinides EA; Costiloe JP
    Psychopharmacologia; 1970; 18(3):260-70. PubMed ID: 4249733
    [No Abstract]   [Full Text] [Related]  

  • 13. Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction.
    Chouinard G; Annable L; Serrano M; Albert JM; Charette R
    Arch Gen Psychiatry; 1975 Oct; 32(10):1295-307. PubMed ID: 1101843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some unusual extrapyramidal complications of psychopharmacotherapy].
    Baudis P; Paceltová L
    Cesk Psychiatr; 1969 Dec; 65(6):390-4. PubMed ID: 5362977
    [No Abstract]   [Full Text] [Related]  

  • 15. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings].
    Prusoff BA; Williams DH; Weissman MM; Astrachan BM
    Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.
    St-Jean A; Ban TA; Scott J
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):483-6. PubMed ID: 4961168
    [No Abstract]   [Full Text] [Related]  

  • 19. Greater than recommended drug dosages--some effects.
    Kline NS
    Am J Psychiatry; 1970 Jun; 126(12):1799. PubMed ID: 5441737
    [No Abstract]   [Full Text] [Related]  

  • 20. Pimozide in chronic schizophrenic patients.
    Huber W; Serafetinides EA; Colmore JP; Clark M
    J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.